Targeted radiation zaps Hard-to-Treat cancers in first human trial
Disease control
Recruiting now
This study tests a new drug that delivers radiation directly to cancer cells with a specific marker (GRPR). It is for adults with advanced cancers like prostate, breast, lung, or colon cancer that have come back or spread. The main goal is to find a safe dose and check for side e…
Phase: PHASE1 • Sponsor: Orano Med LLC • Aim: Disease control
Last updated May 06, 2026 16:03 UTC